Pharma R&D Today
Ideas and Insight supporting all stages of Drug Discovery & Development
Infographic: Elsevier’s Professional Services team provides COVID-19 insights
Posted on May 1st, 2020 by Matthew Morton in COVID-19
Check out a special infographic we created to show how Elsevier’s Professional Services team can support your COVID-19 research.
(more…)Five drug development strategies to combat 2019 novel coronavirus
Posted on April 15th, 2020 by Dr. Anton Yuryev in COVID-19
This article was originally published on Feb 28, 2020, and has been updated on Apr 13, 2020.
Coronavirus disease 19 (COVID-19) has rapidly spread from its starting point in Wuhan, China. As of February 23, 2020, a total of 32 countries and territories have reported 78,811 cases (98% in China) and 2462 deaths [1]. The international scientific community is in a race against time. Researchers across the globe are collaborating to develop antivirals and vaccines to contain the spread of 2019 novel coronavirus (SARS-CoV-2).
(more…)AI in Drug Discovery Has Great Potential – But Also Significant Barriers
Posted on May 1st, 2019 by Nicki Catchpole in Pharma R&D
Elsevier’s Tim Miller’s article in World Pharma Today provides a insightful lens into the reality behind the complexities of implementing artificial intelligence into the R&D cycle. While great strides have been made, the runway to realize the potential is a long one and there are many exciting discoveries left to be made and obstacles to overcome.
(more…)Elsevier is recognized as ‘Best of Show Award Finalist’ and ‘Innovative Practices Finalist” at Bio-IT World Conference & Expo 2019
Posted on April 29th, 2019 by Veaceslav Mamaliga in Pharma R&D
Elsevier held a prominent place at last weeks Bio-IT World conference, recognized as a finalist for both ‘Best of Show’ as well as ‘People’s Choice. Highlighted was Elsevier’s Entellect, a new platform for integrated data management in pharmaceutical and life sciences industries.
(more…)
